Amedeo's Top 20

Amedeo Smart

Independent Medical Education


18 March 2024

Multidisciplinary Journal Club

  1. .
    Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.
    Lancet 2024.

  1. Sprouse Blum AS, DaSilva LA, Greenberg MD, Nissenbaum AJ, et al.
    Comparison of migraine with left- versus right-sided headache: A cross-sectional study.
    Headache 2024.

  2. Poirot MG, Ruhe HG, Mutsaerts HMM, Maximov II, et al.
    Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial.
    Am J Psychiatry 2024;181:223-233.

  3. Selntigia A, Exacoustos C, Ortoleva C, Russo C, et al.
    Correlation between endometriosis and migraine features: Results from a prospective case-control study.
    Cephalalgia 2024;44:333102424123521.

  4. Rajan KB, Mcaninch EA, Wilson RS, Dhana A, et al.
    Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults.
    Neurology 2024;102:e209168.

  1. Guay SP, Paquette M, Taschereau A, Girard L, et al.
    Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia.
    Atherosclerosis 2024.

  2. Rolfzen ML, Palanca BJA, Bartels K.
    Rethinking ketamine as a panacea: adverse effects on oxygenation and postoperative outcomes.
    Br J Anaesth 2024;132:635-638.

  3. Khan WA, Oliver M, Crabtree JH, Clarke A, et al.
    Impact of Prior Abdominal Procedures on Peritoneal Dialysis Catheter Outcomes: Findings From the North American Peritoneal Dialysis Catheter Registry.
    Am J Kidney Dis 2024.

  4. Cleland JGF, Kalra PA, Pellicori P, Graham FJ, et al.
    Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.
    Eur Heart J 2024.

  5. Montalban X, Piasecka-Stryczynska K, Kuhle J, Benkert P, et al.
    Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-s
    Mult Scler 2024.

  1. Guger M, Enzinger C, Leutmezer F, Di Pauli F, et al.
    Early intensive versus escalation treatment in patients with relapsing-remitting multiple sclerosis in Austria.
    J Neurol 2024.

  2. Lutfi A, O'Rourke E, Crowley M, Craig E, et al.
    VTE risk assessment, prevention and diagnosis in pregnancy.
    Thromb Res 2024;235:164-174.

  3. Holloway-Kew KL, Betson AG, Anderson KB, Kotowicz MA, et al.
    Associations between ultra-distal forearm bone mineral density and incident fracture in women.
    Osteoporos Int 2024.

  4. Singh S, Garg A, Tantry US, Bliden K, et al.
    Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes.
    Am J Cardiol 2024.

  5. Kadhum M, Mayr L, Pope-Jones S, Cubitt J, et al.
    Sentinel lymph node biopsy for melanoma in the older population: A prospective analysis of outcomes.
    J Surg Oncol 2024.

  1. Guidet B, Vallet H, Flaatten H, Joynt G, et al.
    The trajectory of very old critically ill patients.
    Intensive Care Med 2024;50:181-194.

  2. Plichta JK, Thomas SM, Wang X, McDuff SGR, et al.
    Survival among patients with untreated metastatic breast cancer: "What if I do nothing?".
    Breast Cancer Res Treat 2024.

  3. Parker SH, Jesso MN, Wolf LD, Leigh KA, et al.
    Human Factors Contributing to Infection Prevention in Outpatient Hemodialysis Centers: A Mixed Methods Study.
    Am J Kidney Dis 2024.

  4. Hegen H, Berek K, Deisenhammer F, Berger T, et al.
    Sex impacts treatment decisions in multiple sclerosis.
    J Neurol 2024.

  5. Colon W, Oriol Mathieu V, Hural J, Hattingh L, et al.
    HIV Diagnostics and Vaccines: It Takes Two to Tango.
    J Infect Dis 2024.


more..


Privacy Policy